Back |
home / stock / pali / pali message board
Subject | By | Source | When |
---|---|---|---|
ronb: 9:18AM 12-10-12Neuralstem presents new ALS NSI-566 data; researchers were able to establ | ronb | investorshangout | 12/10/2012 8:44:40 PM |
ronb: Increasing Price Target - We are raising our 12-month price target from $3.00 to $3.50 per sha | ronb | investorshangout | 12/10/2012 7:02:13 PM |
Serial Investor: Neuralstem to Raise $7.0 Million in Registered Direct Offering | Serial Investor | investorshangout | 09/14/2012 10:44:46 AM |
Serial Investor: Neuralstem Announces Proposed Public Offering | Serial Investor | investorshangout | 09/14/2012 10:43:22 AM |
Serial Investor: Neuralstem Cells Induce Significant Functional Improvement In Permanent Rat | Serial Investor | investorshangout | 09/14/2012 10:41:50 AM |
News, Short Squeeze, Breakout and More Instantly...
Patent includes Composition of Matter claims for both PALI-2108 and PALI-1908 programs Patent includes broad claims for “Gut Microbiota Bioactivated PDE4 Inhibitor Precursors” with similar structure to PALI-2108 and PALI-1908 This patent family provides Composition o...
Company has now completed murine and non-murine pivotal nonclinical studies using GMP PALI-2108 drug substance Company has successfully formulated enteric-coated tablets of PALI-2108 and has demonstrated consistent and reliable drug release profiles Company on track to commence Ph...
Live video webcast on Wednesday, June 26 th at 4:00 PM ET Carlsbad, CA, June 24, 2024 (GLOBE NEWSWIRE) -- Palisade Bio, Inc. (Nasdaq: PALI) (“Palisade” or the “Company”), biopharmaceutical company focused on developing and advancing novel...